Key result
Triglyceride-glucose index >4.70 linked to arterial stiffening in non-diabetic men, unlike HOMA-IR.
Why the study?
Data on the relationship between vascular damage and the novel triglyceride-glucose index were few and heterogeneous, prompting an evaluation of its predictive role for arterial stiffening compared to HOMA-IR.
Does the triglyceride-glucose index (TyG) predict the development of arterial stiffening better than the HOMA-IR index in non-diabetic men?
Cohort (n=527)
Does the triglyceride-glucose index (TyG) predict the development of arterial stiffening better than the HOMA-IR index in non-diabetic men?
p-value: p=0.006
The triglyceride-glucose index is a better predictor of arterial stiffening development than the HOMA-IR index in non-diabetic men.
May support TyG for arterial stiffening risk stratification in non-diabetic men; leaves open superiority to HOMA-IR pending prospective validation.
BACKGROUND AND AIMS: Insulin resistance (IR) is a major risk factor for cardiovascular disease. Recently, a novel index (triglyceride-glucose index-TyG) has been proposed as a surrogate marker of IR and a better expression of IR than the Homeostatic Model Assessment of IR (HOMA-IR) index. Few and heterogeneous data are so far available on the relationship between vascular damage and this novel index. Therefore, we aimed to estimate the predictive role of TyG, in comparison with the HOMA-IR, on the development of arterial stiffening (AS), defined as a pulse pressure>60 mmHg, in an 8-year follow-up observation of a sample of non-diabetic adult men (the Olivetti Heart Study). METHODS AND RESULTS: The analysis included 527 non-diabetic men, with normal arterial elasticity at baseline and not on antihypertensive or hypolipidemic treatment. TyG was significantly greater in those who developed AS than those who did not (p = 0.006). On the contrary, the HOMA-IR index was not different between the two groups (p = 0.24). Similar trends were shown by logistic regression analysis adjusting for main confounders. After the stratification by the optimal cut-off point, values of TyG >4.70 were significantly associated with the development of AS, also after adjustment for main confounders. On the contrary, the HOMA-IR index >1.90 was not associated with the risk of AS development in multivariate models. CONCLUSION: The results of this study indicate a predictive role of TyG on AS, independently of the main potential confounders. Moreover, the predictive power of TyG seems to be greater than that of the HOMA-IR index.
No takes yet. Share an insight, caveat, or question.
D’Elia et al. (2024) conducted a cohort in Non-diabetic adult men (n=527). Triglyceride-glucose index (TyG) vs. HOMA-IR index was evaluated on Development of arterial stiffening (pulse pressure >60 mmHg) (p=0.006). A triglyceride-glucose index >4.70 was significantly associated with the development of arterial stiffening over 8 years in non-diabetic men, whereas HOMA-IR >1.90 was not.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: